Wednesday, April 24, 2024

Grand Rounds: Kristina M. Deligiannidis, M.D.

10:30 AM to 12:30 PM

Rachel Upjohn Building Auditorium and 

webcast via Zoom

“Neuroactive Steroids in the Pathophysiology and Treatment of Peripartum Major Depressive Disorder: A Translational Research Journey”


Activity preview

Kristina Deligiannidis photo

Kristina M. Deligiannidis, M.D.

Director, Women’s Behavioral Health, Zucker Hillside Hospital, Northwell Health
Medical Director, Reproductive Psychiatry, Project TEACH, NYS Office of Mental Health
Professor of Psychiatry, Molecular Medicine and Obstetrics & Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Professor, Feinstein Institutes for Medical Research, Northwell Health
Adjunct Professor of Psychiatry, University of Massachusetts Chan Medical School

Dr. Deligiannidis completed her undergraduate degrees in biology and psychology at the University of Massachusetts at Amherst. As a recipient of pre-doctoral Intramural Research Training awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH). Dr. Deligiannidis completed additional research training at the NIH during medical school and residency in behavioral endocrinology and experimental therapeutics at the National Institute of Mental Health (NIMH). She received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Chan Medical School. After residency she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging.

Dr. Deligiannidis is a national leader in the field of perinatal depression and in novel therapeutics research. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, pregnancy/postpartum periods and perimenopause. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women’s behavioral health. She has authored over 60 peer-reviewed articles plus several textbook chapters and has given over 200 oral/scientific presentations nationally and internationally. Dr. Deligiannidis’ research is supported by NIH R01, foundation and industry research grants. Her research efforts have been nationally recognized with many awards for research and for teaching of medical students and residents. Her research has been covered by major media outlets, including CNN, the Associated Press, NPR, The Boston Globe, Boston and New York ABC and CBS News, Time magazine, Good Morning America and others.

Dr. Deligiannidis is a current board of directors member for the Marcé of North America, past council member of the Society of Biological Psychiatry, past board of directors member for the American Society of Clinical Psychopharmacology and currently is a full member of the American College of Neuropsychopharmacology, where she serves on several committees. Dr. Deligiannidis also serves as a reviewer on over 20 scientific journals and on editorial boards of national and international journals. She serves as a federal grant reviewer for the Center for Scientific Review at NIH. Locally she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women’s Health on Long Island. She additionally serves on Faculty Council and the Zucker Women in Medicine and Science (ZWIMS) Gender and Equity Committee at the Zucker School of Medicine.


Maria Muzik, M.D., M.Sc.

Professor, Departments of Psychiatry, Obstetrics & Gynecology
Co-Director, Zero To Thrive & Women and Infant Mental Health Program
Medical Director, Perinatal Psychiatry Service
Medical Director, MC3 Perinatal Psychiatry Assessment Program Michigan